Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Ploidy and clinical characteristics of childhood acute myeloid leukemia: A NOPHO-AML study.

Sandahl JD, Kjeldsen E, Abrahamsson J, Ha SY, Heldrup J, Jahnukainen K, Jónsson OG, Lausen B, Palle J, Zeller B, Forestier E, Hasle H.

Genes Chromosomes Cancer. 2014 Aug;53(8):667-75. doi: 10.1002/gcc.22177. Epub 2014 Apr 18.

PMID:
24753324
2.

Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia.

Balgobind BV, Hollink IH, Arentsen-Peters ST, Zimmermann M, Harbott J, Beverloo HB, von Bergh AR, Cloos J, Kaspers GJ, de Haas V, Zemanova Z, Stary J, Cayuela JM, Baruchel A, Creutzig U, Reinhardt D, Pieters R, Zwaan CM, van den Heuvel-Eibrink MM.

Haematologica. 2011 Oct;96(10):1478-87. doi: 10.3324/haematol.2010.038976. Epub 2011 Jul 26.

3.

The incidence peaks of the childhood acute leukemias reflect specific cytogenetic aberrations.

Forestier E, Schmiegelow K; Nordic Society of Paediatric Haematology and Oncology NOPHO.

J Pediatr Hematol Oncol. 2006 Aug;28(8):486-95.

PMID:
16912588
4.
5.

Poor survival in t(8;21) (q22;q22)-associated acute myeloid leukaemia with leukocytosis.

Billström R, Johansson B, Fioretos T, Garwicz S, Malm C, Zettervall O, Mitelman F.

Eur J Haematol. 1997 Jul;59(1):47-52.

PMID:
9260580
6.

Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.

Manola KN, Panitsas F, Polychronopoulou S, Daraki A, Karakosta M, Stavropoulou C, Avgerinou G, Hatzipantelis E, Pantelias G, Sambani C, Pagoni M.

Cancer Genet. 2013 Mar;206(3):63-72. doi: 10.1016/j.cancergen.2013.01.001. Epub 2013 Feb 12.

PMID:
23411131
7.

Cytogenetic abnormalities in childhood acute myeloid leukaemia: a Nordic series comprising all children enrolled in the NOPHO-93-AML trial between 1993 and 2001.

Forestier E, Heim S, Blennow E, Borgström G, Holmgren G, Heinonen K, Johannsson J, Kerndrup G, Andersen MK, Lundin C, Nordgren A, Rosenquist R, Swolin B, Johansson B; Nordic Society of Paediatric Haematology and Oncology (NOPHO); Swedish Cytogenetic Leukaemia Study Group (SCLSG); NOPHO Leukaemia Cytogenetic Study Group (NLCSG).

Br J Haematol. 2003 May;121(4):566-77.

PMID:
12752097
8.

Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.

von Neuhoff C, Reinhardt D, Sander A, Zimmermann M, Bradtke J, Betts DR, Zemanova Z, Stary J, Bourquin JP, Haas OA, Dworzak MN, Creutzig U.

J Clin Oncol. 2010 Jun 1;28(16):2682-9. doi: 10.1200/JCO.2009.25.6321. Epub 2010 May 3.

PMID:
20439630
9.

Cytogenetic and hematologic findings in acute myelogenous leukemia, M2 according to the FAB classification.

Oshimura M, Ohyashiki K, Mori M, Terada H, Takaku F.

Gan. 1982 Apr;73(2):212-6.

PMID:
6956530
10.

Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study.

Inaba H, Zhou Y, Abla O, Adachi S, Auvrignon A, Beverloo HB, de Bont E, Chang TT, Creutzig U, Dworzak M, Elitzur S, Fynn A, Forestier E, Hasle H, Liang DC, Lee V, Locatelli F, Masetti R, De Moerloose B, Reinhardt D, Rodriguez L, Van Roy N, Shen S, Taga T, Tomizawa D, Yeoh AE, Zimmermann M, Raimondi SC.

Blood. 2015 Sep 24;126(13):1575-84. doi: 10.1182/blood-2015-02-629204. Epub 2015 Jul 27.

11.

Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial.

Schweitzer J, Zimmermann M, Rasche M, von Neuhoff C, Creutzig U, Dworzak M, Reinhardt D, Klusmann JH.

Ann Hematol. 2015 Aug;94(8):1327-36. doi: 10.1007/s00277-015-2383-2. Epub 2015 Apr 28.

12.

[Complex karyotype abnormalities in pediatric acute myeloid leukemia].

Fleĭshman EV, Sokova OI, Kirichenko OP, Konstantinova LN, Metel'kova NF, Popa AV, Shneĭder MM.

Vestn Ross Akad Med Nauk. 2008;(5):3-7. Russian.

PMID:
18589906
13.

A rare cytogenetic presentation of acute myeloid leukemia (AML-M2).

Kumari P, LingappaKavitha B, Obula Reddy C, Mangalagowri M, Madhumathi DS, Mahadeva Prasad M, Raghavendra HV, Premalata CS, Lakshmaiah KC, Mir Mazloumi SH.

Acta Med Iran. 2012;50(12):827-30. Review.

14.

Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: a report from the Childrens Cancer Group.

Barnard DR, Kalousek DK, Wiersma SR, Lange BJ, Benjamin DR, Arthur DC, Buckley JD, Kobrinsky N, Neudorf S, Sanders J, Miller LP, Shina DC, Hammond GD, Woods WG.

Leukemia. 1996 Jan;10(1):5-12.

PMID:
8558938
15.

Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor.

Schoch C, Haase D, Haferlach T, Gudat H, Büchner T, Freund M, Link H, Lengfelder E, Wandt H, Sauerland MC, Löffler H, Fonatsch C.

Leukemia. 1996 Aug;10(8):1288-95.

PMID:
8709633
16.

Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML.

Preiss BS, Bergmann OJ, Friis LS, Sørensen AG, Frederiksen M, Gadeberg OV, Mourits-Andersen T, Oestergaard B, Kerndrup GB; AML Study Group of Southern Denmark.

Cancer Genet Cytogenet. 2010 Oct 15;202(2):108-22. doi: 10.1016/j.cancergencyto.2010.06.013. Erratum in: Cancer Genet Cytogenet. 2011 Feb;204(2):111. Bergman, Olav J [corrected to Bergmann, Olav J].

PMID:
20875873
17.

Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children.

Hurwitz CA, Raimondi SC, Head D, Krance R, Mirro J Jr, Kalwinsky DK, Ayers GD, Behm FG.

Blood. 1992 Dec 15;80(12):3182-8.

18.

Cytogenetic findings in acute leukaemias of infants.

Lampert F, Harbott J, Ritterbach J.

Br J Cancer Suppl. 1992 Aug;18:S20-2.

19.

Prognostic significance of high hyperdiploid and triploid/tetraploid adult acute myeloid leukemia.

Lazarevic V, Rosso A, Juliusson G, Antunovic P, Rangert-Derolf Å, Lehmann S, Möllgård L, Uggla B, Wennström L, Wahlin A, Höglund M, Johansson B.

Am J Hematol. 2015 Sep;90(9):800-5. doi: 10.1002/ajh.24091. Epub 2015 Jul 22.

20.

Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961.

Barbaric D, Alonzo TA, Gerbing RB, Meshinchi S, Heerema NA, Barnard DR, Lange BJ, Woods WG, Arceci RJ, Smith FO.

Blood. 2007 Mar 15;109(6):2314-21. Epub 2006 Dec 7.

Supplemental Content

Support Center